Discover 1,413 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,413
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
for
Advanced Solid Tumor
Location: San Antonio TX, Houston TX, Tampa FL, Sarasota FL,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07070232
Phase1, Phase2, Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: San Antonio TX, Houston TX, St Louis MO, Denver CO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06465069
Phase1, Recruiting
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: San Antonio TX, Houston TX, Dallas TX, St Louis MO,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07029399
Phase1, Recruiting
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Get alerts for new trials in your area by subscribing now
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for
Mesothelioma, Non Small Cell Lung Cancer,
Location: San Antonio TX, Houston TX, Fort Worth TX, Dallas TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05245500
Phase1, Recruiting
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
for
Tumor, Solid, Tumor, Advanced Solid Tumor
Location: San Antonio TX, West Valley City UT
Sponsor: Aadi Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT05661461
Phase1, Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: San Antonio TX, Houston TX, Irving TX, Oklahoma City OK,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06128551
Phase1, Phase2, Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
for
Advanced Solid Tumors With KRAS G12C Mutations,
Location: San Antonio TX, Houston TX, Fairway KS, Dyer IN,
Sponsor: Frontier Medicines Corporation
Sex: All
Age: 18+
Code: NCT06244771
Phase1, Phase2, Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: San Antonio TX, Dallas TX, Kansas City MO, St Louis MO,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06827236
Phase1, Phase2, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: San Antonio TX, Austin TX, Houston TX, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase3, Recruiting
New
A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors
for
Solid Tumor
Location: San Antonio TX, Austin TX
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07703878
Phase1, Recruiting
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
for
Ovarian Cancer, Solid Tumor
Location: San Antonio TX, Houston TX, Oklahoma City OK, Denver CO,
Sponsor: OnCusp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06234423
Phase1, Recruiting
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Location: San Antonio TX, Denver CO, Atlanta GA, Milwaukee WI,
Sponsor: Nammi Therapeutics Inc
Sex: All
Age: 18+
Code: NCT06582017
Phase1, Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: San Antonio TX, Houston TX, Dallas TX, New Orleans LA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase1, Phase2, Recruiting
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: San Antonio TX, Houston TX, Dallas TX, Nashville TN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase1, Recruiting
Multi-Institutional Registry for Prostate Cancer Radiosurgery
for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: San Antonio TX, Austin TX, Houston TX, Fort Worth TX,
Sponsor: RPCR, Inc.
Sex: Male
Age: 18 - 70+
Code: NCT01226004
Recruiting
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
for
Advanced HR+/HER2- Breast Cancer,
Location: San Antonio TX, Nashville TN, Atlanta GA
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07288359
Phase1, Phase2, Recruiting
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body